By transfecting a gene encoding mutated IκBα that is not able to be phosphorylated and thereby inhibits the activation of the NF-κB pathway, similar findings have been demonstrated in that suppressive NF-κB radiosensitizes prostate cancer cells (6). The gene discussed is NFKB1; the disease is prostate carcinoma.